The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...
Coronary artery disease has long been understood through the paradigm of epicardial coronary artery obstruction, causing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback